Prevnar - Analysis Of Production
Number of pages:
10
ABSTRACT:
A 10 page paper. Prevnar is vaccine from Wyeth Lederle. This vaccine has been shown to be effective in preventing invasive pneumococcal disease in small children, in fact, it was credited with reducing the incidence of pneumococcal diseases by 40 percent in its first year. This essay is divided into these sections: product life cycle and market demand; demand forecast; new product development, quality function, and operations system design. The paper explains the FDA approval process, the capabilities of Wyeth, who produces Prevnar, and the demand for the product. 2 illustrations included. Data included. Bibliography lists 7 sources.
FILE NAME:
File: MM12_PGprvnr.rtf
Send Me This Paper
Back to Papers